Superbalife International

Zyrexin 525 mg

Serving
1 Tablet(s)
Per container
15
Form
tablet
DSLD
Avoid-flaggedObjective label signals
Flagged excipients
2
1 avoid · 1 caution
FDA recalls
0
no recall history
CAERS reports
1
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

1 active ingredients
IngredientAmount% DV
Proprietary Herbal Blend
Proprietary Blend (Herb/Botanical)
1050 mg
Flagged excipients

2 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

  • ◐ CAUTIONFD&C Blue #1 Aluminum Lake
    color

    EU requires 'attention in children' warning per Commission Regulation 1333/2008 Annex III. Limited to specific food categories; capsule-shell use permitted with restrictions.

FDA CAERS · adverse event context
1
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Microcrystalline Cellulose Dextrose · Starch · Stearic Acid · Hydroxy Propyl Methycellulose · Magnesium Stearate · Silica · Triacetin